Clinical trial
An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus
NCT00432354 · Buddhist Tzu Chi General Hospital, Other · Unknown status
Key facts
| NCT number | NCT00432354 |
|---|---|
| Title | An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus |
| Lead sponsor | Buddhist Tzu Chi General Hospital, Other |
| Collaborators | Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | atorvastatin |
| Enrollment | 40 |
| Start date | Mar 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Feb 7, 2007 |
| Last update posted | Mar 20, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: